✦ LIBER ✦

Development of criteria for drug utilization review

✍ Scribed by Knapp, David A

Book ID: 109844971
Publisher: Nature Publishing Group
Year: 1991
Tongue: English
Weight: 190 KB
Volume: 50
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.1991.189

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Panel I. Drug utilization review: Criter

Panel I. Drug utilization review: Criteria*

✍ Brater, D Craig; Abernethy, Darrell R; Benedict, Beth; Erwin, W Gary; Franson, T 📂 Article 📅 1991 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Appropriateness and utilization of cardi

Appropriateness and utilization of cardiac CT: Implications for development of future criteria

✍ Meagan K. Murphy; Thomas J. Brady; Khurram Nasir; G. Scott Gazelle; Fabian Bambe 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 276 KB

The definition of drug utilization revie

The definition of drug utilization review: Statement of issues

✍ Erwin, W Gary 📂 Article 📅 1991 🏛 Nature Publishing Group 🌐 English ⚖ 216 KB

Development review of coal ash effective

Development review of coal ash effective utilization technology

📂 Article 📅 2002 🏛 Elsevier Science ⚖ 180 KB

The utility of sulfonate salts in drug d

The utility of sulfonate salts in drug development

✍ David P. Elder; Ed Delaney; Andrew Teasdale; Steve Eyley; Van D. Reif; Karine Ja 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

The issue of controlling genotoxic impurities in novel active pharmaceutical ingredients (APIs) is a significant challenge. Much of the current regulatory concern, has been focused on the formation and control of genotoxic sulfonate esters. This is linked with the withdrawal of Viracept (Nefinavir m

Panel III. Intervention: The use of drug

Panel III. Intervention: The use of drug utilization review outcomes*

✍ McMahon, F Gilbert; Avorn, Jerry; Gross, Alan; Armstrong, Robert; Schulke, David 📂 Article 📅 1991 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB